Neuron23 Appoints Kathy Dong, Pharm.D., MBA to Board of Directors

Experienced pharmaceutical development executive brings track record of advancing preclinical and clinical programs and successful commercial product launches SOUTH SAN FRANCISCO, Calif., June 14, 2022 /PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on...

Click to view original post